Access to Medicine Archives

Return to Access to Medicine Homepage

Archived Media, by date:

February 7, 2019 - Comments of Public Citizen for the 2019 Special 301 Review

January 17, 2019 - Overwhelming Majority of Americans Support Medicare Negotiation: Public Citizen Analysis Finds Misleading Claims About Patient Support in Letter Opposing Efforts to Reduce Prescription Drug Prices

December 4, 2018 - Analysis: NAFTA 2.0: U.S.-Mexico-Canada Agreement Chapter 20, Pharmaceutical Related Patent Provisions (en español here)

October 10, 2018 - No More Secrets: Congress Bans Pharmacist ‘Gag Orders’ On Drug Prices

October 10, 2018 - Trump’s So-Called Medicine ‘Gag Clause’ Ban Barely Scratches the Surface for Consumers in Need of Relief

October 9, 2018 - A Nobel Prize-Winning Cancer Therapy Will Be Unaffordable for Most Americans. Public Pharmaceuticals Can Help Change That

October 5, 2018 - NOTE TO REPORTERS: Doggett’s Medicare Negotiation Plan Frightens Big Pharma, Now Has More Than 100 Co-Sponsors

October 1, 2018 - Potentially Lethal: New NAFTA IP chapter requires 10-year biologics monopolies (worst such rule in a U.S. FTA)

October 1, 2018 - Common Dreams: The Good, the Bad, and the Ugly on NAFTA 2.0

September 5, 2018 - Sen. Smith’s Legislation Would Make Medicines Affordable

September 5, 2018 - UCLA's Patent War in India Prevents Access to Prostate Cancer Treatment Worldwide

September 4, 2018 - Big Pharma, Corporations Dealt a Good Hand With McCain’s Replacement

August 29, 2018 - Trade deal between U.S. and Mexico is criticized for allowing high drug prices to continue

August 7, 2018 - Azar’s Prescription Cost Plan Needs Closer Scrutiny

August 2, 2018 - This Bill Would Help Us Afford Prescription Drugs

July 27, 2018 - Vermont Representative Among Sponsors Of Prescription Drug Pricing Bill

July 25, 2018 - [STAT +] Democrats introduce a bill to allow Medicare negotiations and sidestep patents if talks fail

July 24, 2018 - Legislation Would Provide Leverage Through a Competitive License to Allow Competition If Negotiations Fail

July 24, 2018 - [Inside Health Policy] Public Citizen Touts Doggett's Souped-Up Part D Drug Negotiation Bill

July 17, 2018 - Activists Are Urging the FDA to Break the Patent on Truvada. Here’s Why

July 17, 2018 - Consumer Groups Letter on Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs

July 17, 2018 - Industry responds to Trump's drug plan with more finger-pointing

July 17, 2018 - Public Citizen Comments Regarding HHS Blueprint to Lower Drug Prices and Reduce Out of Pocket Costs

July 12, 2018 - Pfizer doesn't deserve any credit for 'rolling back' its price increases at Trump's demand. Here's why

July 5, 2018 - Local Health Departments Pay High Price For Opioid Overdose Drug [Behind Paywall]

June 26, 2018 - Press Release: Activists, Organizers and Advocates Gather to Fight Big Pharma 

May 30, 2018 - Editorial: Trump's drug plan is not a prescription for savings

May 25, 2018 - Profiteering from the opioid crisis

May 21, 2018 - Can an Obscure, 100-Year-Old Patent Law Take On Big Pharma?

May 11, 2018 - Trump plan for drug prices seen largely sparing industry

May 11, 2018 - Opinion: Narcan saved me from an opioid overdose. President Trump should make this drug cheaper.

May 10, 2018 - White House Set to Announce Plan to Curb Drug Prices

May 7, 2018 - Trump made high drug prices his issue. Democrats think they can take it back.

May 4, 2018 - Trump to deliver major address on drug prices, but advocates predict small steps

May 3, 2018 - Fact Sheet: About Government Use of Patented Inventions

May 3, 2018 - Fact Sheet: About the Public Citizen, Baltimore City Health Department Naloxone Request

May 3, 2018 - Letter: Public Citizen, Baltimore City Health Department Request Trump Administration Exercise Government Use Authority on Naloxone Treatments

May 3, 2018 - Gov’t urged to invoke authority to boost OD antidote access

May 2, 2018 - Brook Baker: Lies, Distortions, and False Promises: The U.S. Position on Compulsory Licenses in the 2018 Special 301 Report

April 27, 2018 - Press Release: Trump to the World: Raise your Medicine Prices --- Or Else

April 25, 2018 - US Waits for Trump to Tackle Drug Pricing as Big Pharma Goes on Lobbying Blitz

April 23, 2018 - Note to Reporters: Trump Needs to Rethink Prescription Prices in Light of Canceled Speech 

April 10, 2018 - Drug companies paid $116 million to patient advocacy groups in 2015 alone, new data suggests

March 15, 2018 - The Sick Paying for the Healthy: How Insurance Companies Drive Up Drug Prices

March 15, 2018 - Public Citizen Statement for Special 301 Hearing March 2018

March 15, 2018 - Public Citizen letter to Congress regarding omnibus spending package and the Medicare Part D donut hole

February 23, 2018 - Trump wants lower drug prices. Menendez's Republican challenger fought to keep them high.

February 19, 2018 - Public Citizen Analysis: The Good, the Bad and the Ugly of the Trump Administration’s Drug Pricing Measures from its FY 2019 Budget Proposal

February 17, 2018 - Trump wants lower drug prices. Menendez's Republican challenger fought to keep them high

February 12, 2018 - McCain and Baldwin to Trump: Hold pharma’s feet to the fire on drug prices

February 9, 2018 - Comments of Public Citizen for the 2018 Special 301 Review

February 8, 2018 - Senate Republicans Kept Provision to Fight High Drug Prices Out of Spending Bill, Democrats Say

January 29, 2018 - Peter Maybarduk on Busting up Big Pharma’s Monopoly Power

January 15, 2018 - Public Citizen Comment on the draft guidance and recommendations put forth by the Connecticut Health Cost Commission (the Commission) on the topic of controlling prescription drug prices

January 12, 2018 - Other98: Our Would-Be Health Secretary Said Some Pretty Sick Stuff in His Confirmation Hearing

January 12, 2018 - LA Times: Trump's pick for health secretary makes clear he's totally the wrong guy for the job

January 11, 2018Public Citizen Comments to the FDA Supporting Draft Guidance Restricting Orphan Drug Designations for Pediatric Uses

January 10, 2018 - Common Dreams: 'No One Should Be Fooled': Warren Rips Trump's HHS Pick Over Desire to Gut Medicaid

January 9, 2018 - Senate Finance Committee evaluates Alex Azar to be the next HHS secretary

January 3, 2018 - Civil Society Letter Urging Senators to Reject the Nomination of Alex Azar for HHS Secretary

December 21, 2017 - Letter to Spark Therapeutics About Luxturna Research and Development

December 5, 2017 - Managed Care Mag: Drug Prices - Why so high and why so #&*! complicated

November 28, 2017 - The Hill: Fight erupts over tax credit for 'orphan' disease drugs

November 15, 2017 - With Trump's HHS pick Big Pharma takes over our health system - by Justin Mendoza, Organizer, Access to Medicines Program

November 13, 2017 - Common Dreams: 'Why Not Freddy Krueger?' Trump Picks Big Pharma Exec Alex Azar to Head HHS

November 4, 2017 - Ohio’s Opportunity to Take Control of Medicine Prices

November 3, 2017 - Civil Society Letter to Senate re: CHIP/Health Care Offsets

November 1, 2017 - Consumer Affairs: State governments take on drug companies to curb rising prices

October 19, 2017 - Civil Society Letter to Senate Judiciary Committee re: Allergan Mohawk Scheme

October 5, 2017 - Morning Consult: Grassley Pressing to Include Drug Pricing Measures in CHIP Reauthorization

October 2, 2017 - Fierce Pharma: AbbVie promises it's sticking with CEO's price-hike pledge, at least through 2018

September 26, 2017 - Did someone say pledge? AbbVie may reverse its promise on price hikes - by Ed Silver

September 25, 2017 Nevada's drug-pricing law faces new court hearing next month

September 25, 2017 - Public Citizen Finance Hearing Statement on Graham Cassidy

September 20, 2017 - Public Citizen Written Comments on FDA Public Meeting: "Administering the Hatch-Waxman Amendments: Ensuring a Balance Between Innovation and Access"

September 18, 2017 California Drug Price Bill Sweeping In Scope, Lacking In Muscle

September 18, 2017 - Citizen Lobbying Kit on Drug Prices

July 24, 2017 - Trump’s Plan to Make Drugs Cheaper Could End Up Making Them More Expensive

July 19, 2017 - Public Citizen Testimony at FDA Hearing: "Administering the Hatch-Waxman Amendments: Ensuring a Balance Between Innovation and Access"

July 11, 2017 - Drug cost proposals lack Trump's campaign pledges, consumer watchdog says

July 6, 2017 - Brief: Will Trump Adopt Pharma's Proposals on Value-Based Pricing?

July 6, 2017 - Brief: Generic Exclusivity Expansion is Unlikely to Lower Prescription Drug Prices

July 6, 2017 - Brief: Generic Priority Review Vouchers are Not the Answer to Price Gouging

July 6, 2017 - Leaked Discussion Documents on the Trump Adminstration's Drug Prices Agenda

June 30, 2017 - Civil Society Letter to Senator Ron Wyden regarding India's intellectual property rights policies.

June 30, 2017 - First Post: US pressure on India to grant more patents on pharma products 'appalling', say health advocates

June 26, 2017Statement: Trump and Modi Discussions: A Matter of Life and Death

June 26, 2017Trump's Plan for Drug Pricing Executive Order Is a Big Pharma Wish List

June 23, 2017 - Statement: Draft Trump Executive Order Abandons Promises to Challenge Big Pharma and Make Medications Affordable

June 20, 2017 - What Trump Should Do to Lower Medicine Prices

June 20, 2017 - Exporting Monopoly Rules Does Not Lower U.S. Prescription Drug Prices

June 20, 2017Statement: Draft Trump Order Abandons Campaign Promises to Challenge Big Pharma and Make Medications Affordable

June 16, 2017 - Report: Key Questions on Patent Disclosure Requirements for Genetic Resources and Traditional Knowledge by Burcu Kilic for the World Intellectual Property Organization.

June 16, 2017 - Note to Reporters: Trump Administration Meets on Pharmaceutical Proposals, We Can Tell You How They Will Affect Patients

June 15, 2017 - Press Release: Brown-Gillibrand Bill Would Stop Pharma Price Gouging

June 7, 2017 - Comments from Public Citizen and civil society group re: Louisiana hepatitis C drug pricing

June 7, 2017 - Statement: House Energy and Commerce Members Challenge Administration to Increase Access to Medicines

May 18, 2017 - Are we finally ready to do something about Big Pharma’s price-gouging? by Steve Knievel and Dr. Azza AbuDagga of Public Citizen

May 17, 2017 - New Haven Register:  Support bill for lower drug prices: Letter to the editor by Justin Mendoza:

May 11, 2017 - The Pharma Letter: A move to help patients or create exclusive cartel? Mixed views on PhRMA’s big change

May 10, 2017 - Letter: Pass the Creating and Restoring Equal Access to Equivalent Samples Act of 2017

May 10, 2017 - Data exclusivity in the Regional Comprehensive Economic Partnership (RCEP)

May 10, 2017 - Report: Data exclusivity in the Regional Comprehensive Economic Partnership (RCEP)

May 9, 2017 - Statement: Big Pharma to Become Even More Exclusive, More Expensive Cartel In False Attempt to Gain Friends

May 4, 2017 - Statement:Trumpcare Would Repeal Prescription Coverage and Provide Tax Breaks for Big Pharma

April 27, 2017 - Letter: Pass the Creating and Restoring Equal Access to Equivalent Samples Act of 2017 (CREATES Act)

April 20, 2017 - New York Times: How to Stop Drug Price Gouging   

April 11, 2017 - Public Eye: Compulsory Licensing in Colombia: Leaked Documents Show Aggressive Lobbying by Novartis

April 11, 2017 - Press Release: Just Three of World’s Top 28 Pharmaceutical Corporations Agree to Limit Price Hikes to Single Digits

April 11, 2017 - Report: Large Majority of Prescription Drug Corporation CEOs Will Not Commit to Limiting Price Increases * AbbVie, Inc. pledged at the time of this report's publication that it would limit price increases to single digits. On September 25, 2017 Fierce Pharma reported that executives have gone back on this pledge, saying the company "has the flexibility to revert to more than one price increase per year and to double-digit increases in 2018 and beyond."

April 10, 2017 - The Intercept: Big Pharma Funds “Independent” Advocacy Groups Attacking Drug-Price Reduction Bill

April 7, 2017 - Truthout: Could Legalizing Prescription Drug Imports Break Big Pharma?

April 4, 2017 - Statement: Public Citizen Applauds Rep. Doggett and 50 Members of Congress Who Called on Trump to Use His Authority to Lower Medication Prices

April 3, 2017 - CNN: When $65,000 a year for a drug is applauded

March 31, 2017 - Press Release: Pharmaceutical Industry Profits Exceed R&D Costs in 2013, 2014 and 2015

March 31, 2017 - Report: Pharmaceutical Industry Profits Exceed Industry's Self-Reported R&D Costs

March 30, 2017 - Letter from civil socitey to congressional leadership in opposition to proposed cuts to the NIH and Fogarty International Center in the White House budget

March 29, 2017 - Senators and members of Congress introduce far-reaching legislation to Improve Access to Affordable Prescription Drugs

March 29, 2017 - Press Release: Landmark Legislation Would Lower U.S. Prescription Prices

March 28, 2017 - New York Times: Severe Eczema Drug is Approved by F.D.A.; Price Tag is $37,000 a Year

March 15, 2017 - STAT: Cancer Patients Skipping Medicines or Delaying Treatment Due to High Drug Prices

March 6, 2017 - Peter Maybarduk Testimony in Support of SB 442, Connecticut Drug Pricing Transparency Bill

March 1, 2017 - Nature: Hepatitis C Drugs Re-energize Global Fight over Patents

February 21, 2017 - Cox Washington Bureau: Senators Demand Answers Over Skyrocketing Prices for Overdose Drug

February 19, 2017 - CTV News: Outrageous price, approval a concern for drug to treat deadliest genetic disease afflicting children

February 17, 2017 - STAT: Pharma trade group urges US trade rep to take action against Colombia

February 10, 2017 - Statement: In Strict Party-Line Vote, Senate Republicans Confirm Tom Price as Secretary of Health and Human Services

February 9, 2017 - Public Citizen Comments for USTR's 2017 Special 301 Review

February 6, 2017 - Truthout: Big Pharma Launches Sentimental Ad Campaign to Distract From Skyrocketing Drug Prices

February 4, 2017 - NPR: Drugmaker Kaleo Raises Price of Life-Saving Drug by Thousands

February 3, 2017 - RNZ: US President Signals Paying More for Medicines FTA Bottom Line

January 31, 2017 - Washington Post: Democrats Block Confirmation Votes for Sessions, Price and Mnuchin

January 31, 2017 - Washington Post: Trump Calls for Lower Drug Prices, Fewer Regulations in Meeting with Pharmaceutical Executives

January 31, 2017 - New York Times: Trump Vows to Ease Rules for Drug Makers, but Again Zeros In on Prices

January 31, 2017 - Bloomberg: Mylan Faces U.S. Antitrust Investigation on EpiPen

January 30, 2017 - The Huffington Post: Trump, Democrats and the Left Killed Obama’s Big Trade Deal. Here’s How it Happened?

January 27, 2017 - Devex: Zika vaccine could be delayed, unaffordable after US Army grants exclusive rights to pharma company

January 24, 2017 - Public Citizen: Impression Products, Inc. v Lexmark International, Inc

January 17, 2017 - Media Alert: U.S. Rep. Tom Price Should Not Be Confirmed As HHS Secretary

December 13, 2016 - Statement by Steve Knievel: HHS Report Suggests That Patient Health Continues to Take a Back Seat to Medical Companies’ Pursuit of Maximum Profits

December 12, 2016 - IP Watch: UAEM Targets Accessible Medicines, R&D Financing, Publicly Funded Research

December 12, 2016 - The Hill: Gilead CEO’s Apology for Drug Prices are Useless When No Action is Taken

December 11, 2016 - New York Times: Lives and Profits in the Balance: The High Stakes of Medical Patents

December 9, 2016 - New York Times: Wary Drug Makers Move to Fend Off Further Attacks Under Donald Trump

December 6, 2016 - IP Watch: TPP May be Dead - But Its Impact Lingers

December 5, 2016 - Harvard Law’s Bill of Health: What is the Right Number of Unsafe, Ineffective Drugs for the FDA to Approve?

December 5, 2016 - Los Angeles Times: The 21st Century Cures Act: A Huge Handout to the Industry Disguised as a Pro-Research Bounty

December 1, 2016 - STAT: 21st Century Cures Act Would Distort the Meaning of FDA Approved

December 1, 2016 - Business Standard: Would Washington's FDA Fix Cure the Patients or the Drug Industry?

December 1, 2016 - The Atlantic: Congress Nears a Breakthrough on Medical Research Funding

December 1, 2016 - Drug Money: FDA Depends on Industry Funding; Money COmes with “Strings Attached”

December 1, 2016 - Drug Money: In FDA Meetings, “Voice” of the Patient often Funded by Drug Companies

November 30, 2016 - Statement: 21st Century Cures: Bad Deal for Patients. Senate Should Reject

November 30, 2016 - Los Angeles Times: House Approves Sprawling Bill that Would Expand Medical

November 30, 2016 - Health Affairs Blog: The 21st Century Cures Act is Still a Bad Deal for Patients

November 30, 2016 - Washington Post: Bill Expediting New Medical Treatments Passes House

November 30, 2016 - Star Tribune: U.S. House Passes 21st Century Cures Act

November 30, 2016 - STAT: House Approves Landmark 21st Century Cures Act, Sending Landmark Bill to the Senate

November 28, 2016 - Statement: Sanders Statement on the 21st Century Cures Act

November 28, 2016 - STAT: Elizabeth Warren rips 21st Century Cures bill and vows to fight it

November 28, 2016 - Updated Fact Sheet: Preventing Patient Harm in 21st Century Cures (Nov. 28 version)

November 28, 2016 - Wall Street Journal: Drugmakers Find Competition Doesn’t Keep a Lid on Prices

November 26, 2016 - Wall Street Journal: Lawmakers Try for Year-End Bill on Medical Research, Devices and Opioid Addiction

November 25, 2016 - NPR: Legislation That Would Shape FDA And NIH Triggers Lobbying Frenzy

November 21, 2016 - Fact Sheet: Preventing Patient Harm in 21st Century Cures and Beyond (Nov. 21 version)

November 21, 2016 - The Hill: Lawmakers must ask tough questions about the 21st Century Cures Act

November 18, 2016 - Washington Post: Letter: Big Pharma-backed bill won’t cure the FDA

November 18, 2016 - Yes! Magazine: How a Battle Over Affordable Medicine Helped Kill the TPP

November 17, 2016 - Statement: Fraud Charges Are Welcome in Valeant, Philidor Kickback Scheme

November 15, 2016 - Statement: TPP RIP

November 14, 2016 - USA Today: Some Medicare, Medicaid drug prices soar as reform uncertain

November 13, 2016 - La Republica: Peter Maybarduk: “El nivel de protección monopólico para medicinas subirá con el TPP”

November 11, 2016 - Medium: No, Trump Didn’t Kill the TPP — Progressives Did

November 7, 2016 - America - The National Catholic Review: Remedies Beyond Reach

November 3, 2016 - Public Citizen, Consumers Union and others send letter calling on Congress not to advance the so-called 21st Century Cures package during the lame duck sessions

November 1, 2016 - Washington Monthly: Just the Medicine -- How the next president can lower drug prices with the stroke of a pen.

October 28, 2016 - New York Times: The U.S. Is Standing in the Way of Cheaper Drugs for the Poor

October 28, 2016 - Foreign Affairs: The TPP and Drug Prices -- Not a Settled Matter

October 27, 2016 - Neritam: A Mother’s Plea to CEO After EpiPen Price Jumped 400%

October 27, 2016 - Morning Consult: House Democrats Still Working Toward Agreement on Cures

October 27, 2016 - Politico: Why Liberal Groups Want ‘Cures’ Legislation Put on Ice

October 27, 2016 - World Health Organization: Over 1 million treated with highly effective hepatitis C medicines

October 26, 2016 - Inside Health Policy: Labor Unions, Advocates: Don’t Move on Cures Without Drug Pricing Reforms

October 26, 2016 - The Hill: Liberal Groups Call for Delaying Cures Bill to Next Year

October 26, 2016 - Letter from AARP, AFL-CIO, Consumers Union, Doctors Without Borders & Oxfam America calling on President Obama not to include damaging biologics language in implementing legislation for TPP or in related side letters

October 25, 2016 - International Journal of Health Services: The Trans Pacific Partnership Agreement and Pharmaceutical Regulation in Canada and Australia

October 24, 2016 - Elliott: I’m Being Charged More for my Prescription Drugs. What’s Going on Here?

October 18, 2016 - Fair Warning: Swarms of Drug Industry Lobbyists and Campaign Cash Stymie Bid to Restrain Medicare Prescription Costs

October 17, 2016 - STAT: HHS is urged to allow a drug maker to export cheap versions of pricey cancer med

October 12, 2016 - Press Release: Rep. Pocan Urges President Obama to Take Executive Action to Lower Prescription Drug Prices

October 11, 2016 - The Wire: US’s Inconsistent Policies on Pharma Could Compromise Global Access to Medication

October 10, 2016 - Politico: Groups Take Aim at Pharma in TTIP

October 3, 2016 - Common Dreams: In Boon for Big Pharma, TTIP Would Lock In High Drug Prices: Report

October 3, 2016 - Policy Report from Public Citizen, Health Action International and Commons Network: TTIP and Affordable Medicines - How TTIP May Obstruct Progress Towards Sustainable Access To Medicines

September 22, 2016 - Al Jazeera English: Mylan CEO faces tough questioning in Congressional EpiPen hearing (video)

September 21, 2016 - Fact Sheet: Reality Checking Mylan CEO’s Testimony on EpiPen Prices

September 20, 2016 - Press Release: American EpiPen Price as Much as Nine Times Higher than in Other Wealthy Countries, Public Citizen Survey Shows

September 11, 2016 - Chicago Sun Times: Editorial: Get to bottom of drug company overpricing

September 3, 2016 - The Independent Record: Insulin price scandal hurts many more than EpiPen issues

September 1, 2016 - Washington Post: Mylan, corporate tax deserter, is taking those EpiPen profits and fleeing the country

August 31, 2016 - STAT: How Mylan tried to keep Teva from selling a generic EpiPen

August 31, 2016 - Storify: Outrage Against EpiPen Price-Gouging & Action Demanding Mylan Reverse the Price Hikes

August 30, 2016 - WTAE Pittsburgh: Protesters demand change at headquarters of Mylan Pharmaceuticals

August 30, 2016 - Pittsburgh Post-Gazette: EpiPen furor brings protestors to Mylan headquarters in Cecil

August 30, 2016 - NPR: Activists Deliver Petitions To EpiPen Maker’s Canonsburg Headquarters

August 30, 2016 - Public Citizen's Photos from the EpiPen Petition Delivery

August 30, 2016 - Statement: Mylan Must Lower EpiPen Price

August 30, 2016 - Press Release: Public Interest Groups to Mylan: Reverse the EpiPen Price Hikes Immediately

August 30, 2016 - Democracy Now!: Why Are We Paying $300 for an EpiPen That Holds Only $1 Worth of Medicine?

August 29, 2016 - Washington Post: House Oversight Committee investigating drugmaker Mylan over EpiPen price hike

August 29, 2016 - Washington Post: Mylan to introduce a half-price generic version of EpiPen

August 29, 2016 - New York Times: Mylan Tries Again to Quell Pricing Outrage by Offering Generic EpiPen

August 29, 2016 - NBC Nightly News: Full Broadcast -- segment on EpiPen Price Hikes with Peter Maybarduk begins at minute 9:20

August 29, 2016 - Huffington Post: EpiPen Maker’s Latest Offer: Still Not Good Enough (authored by Public Citizen President Robert Weissman)

August 29, 2016 - Media Advisory: Groups to Mylan: EpiPen Discounts for Some Consumers Not Enough, True Price Reduction and Federal Reforms Needed

August 25, 2016 - Statement: Mylan’s Announcement on EpiPen Prices: Too Little Too Late

August 24, 2016 - Petition: Stop Immoral Price Gouging for Life-Saving EpiPen

August 23, 2016 - Kaiser Health News: Government-Protected ‘Monopolies’ Drive Drug Prices Higher, Study Says

August 22, 2016 - New York Times: EpiPen Price Rise Sparks Concern for Allergy Sufferers

August 16, 2016 - USA Today: For drug price reform, patients need to connect: Your Say

August 10, 2016 - California Healthline: Can Drug Price Transparency Keep Costs Down?

August 4, 2016 - Washington Post: High prices make once-neglected ‘orphan’ drugs a booming business

August 4, 2016 - STAT News: Pharma dollars back patient groups that oppose Medicare Part B overhaul

August 4, 2016 - Report: Patients' Groups and Big Pharma -- Three in Four Patients’ Groups That Sided With the Pharmaceutical Industry Against Medicare Drug Price Reforms Received Industry Money

August 4, 2016 - Press Release: Majority of Patients’ Groups Siding With Big Pharma Against Medicare Part B Pricing Reforms Receive Industry Funding

August 4, 2016 - CitizenVox: Pharma Funding Among Patients' Groups

July 25, 2016 - AP: What Are the Top 20 Priciest Medicare Prescription Drugs?

July 25, 2016 - STAT: State Department accused of interfering with efforts for affordable medicines

July 22, 2016 - Huffington Post: Right To Health, Colombia And US Congress (authored by Todd Howland, Representative of the UN High Commissioner for Human Rights in Colombia)

July 21, 2016 - CitizenVox: An Important Remedy for Pharma's Exorbitant Pricing

July 21, 2016 - Forbes: How Abbvie's Humira Undercuts The Drug Industry Price Defense

July 20, 2016 - Letter from 56 Non-profit Organizations and Academic Experts to Secretary Kerry Regarding State Department Pressure Against Access to Medicines Efforts

July 20, 2016 - Public Health, Human Rights and Faith Organizations Question State Department Pressure Against Global Access to Medicines Initiatives

July 16, 2016 - New York Times: Makers of Humira and Enbrel Using New Drug Patents to Delay Generic Versions

July 15, 2016 - Huffington Post: Taxpayers Funded A Lifesaving Drug And Guess What Happened Next (authored by Sen. Bernie Sanders)

July 14, 2016 - Public Citizen joins generics industry representatives and others in letter supporting the CREATES Act

July 13, 2016 - CitizenVox: Pharma (contribution) Addicts in Congress

July 12, 2016 - Public Citizen joins consumer groups in letter supporting the CREATES Act

July 11, 2016 - Report: Pharma's Orders -- U.S. Representatives Who Sided With Big Pharma in Medicare Lobbying Fight Received 82% More Industry Campaign Contributions

July 11, 2016 - Action: Tell Congress -- Serve the People, NOT Big Pharma

July 11, 2016 - Press Release: Pharmaceutical Industry Funding Influences Lawmakers in Contentious Medicare Part B Reform Battle

July 8, 2016 - Public Citizen letter in U.S. News and World Report: An Overdue Fix for Medicare

July 1, 2016 - Letter from Public Citizen to U.S. Congress Conference Committee for the Comprehensive Addiction and Recovery Act

June 28, 2016 - Media Advisory: Press Call to Explore NIH Patent Policies Compromising Medicine Affordability, the Agency’s Transparency, More

June 27, 2016 - Public Citizen Joins Coalition in Letter Supporting and Calling for Improvements to CMS' Medicare Part B Prescription Drug Pricing Demonstration

June 24, 2016 - Press Release: Bipartisan Legislation Could Help Reduce Prices of Lifesaving Medications

June 24, 2016 - Colombian civil society statement on Resolution 2475

June 23, 2016 - Press Release: Schakowsky, Brown, McCain Introduce Bipartisan Legislation to Lower Costs of Life-Saving Drugs

June 23, 2016 - Press Release: Brown, McCain, Schakowsky Introduce Bipartisan Legislation to Lower Costs of Life-Saving Drugs

June 21, 2016 - Slate: The U.S. Chamber of Commerce’s IP Myth

June 16, 2016 - Medium: The High Health Costs of TPP’s “Free Trade” (authored by Joseph Stiglitz)

June 20, 2016 - Statement: Colombia Ministry of Health Ignores Corporate Threats and Possible U.S. Interference, Improves Affordable Access to Cancer Treatment

June 20, 2016 - Statement: NIH Turns Its Back on Patients; Decision to Refuse Generic Competition With Xtandi Harms Public Health

June 20, 2016 - NIH Director Francis Collins Final Response to Xtandi March-in Petition

June 17, 2016 - Reaction of AFIDRO, association of patent-based pharmaceutical companies, to Colombian Ministry of Health public interest declaration on imatinib

June 17, 2016 - Colombia Ministry of Health Resolution 2475 of 2016, declaring imatinib in the public interest

June 16, 2016 - La Silla: Alejandro Gaviria supera un obstáculo pero no tiene ganada la carrera

June 10, 2016 - The Nation: The Trans-Pacific Partnership Will Hurt Farmers and Make Seed Companies Richer

June 10, 2016 - KEI: Novartis complaints over public interest declaration debunked

June 9, 2016 - STAT News: Colombia plans to unilaterally lower the cost of a Novartis cancer drug

June 9, 2016 - Audio from Minister Gaviria's press conference on imatinib, in Spanish

June 9, 2016 - AP: Colombia to force Novartis to lower prices of cancer drug

June 9, 2016 - Reuters: Colombia to set new price for Novartis cancer drug: minister

May 29, 2016 - El tiempo: Cara y sello del debate por el fármaco contra la leucemia

May 27, 2016 - Letter from Colombian Ministry to Civil Society Clarifying that Compulsory Licenses Do Not Constitute Expropriation under Colombian Law

May 27, 2016 - Campaign for America's Future: Sanders, Brown Speak Out On Gunboat Diplomacy For Corporations

May 27, 2016 - Press Release: Groups Demand Answers from Obama Administration Regarding Alleged U.S. Interference in Colombian Health Measure (see the letter here)

May 26, 2016 - STAT: Bernie Sanders accuses US Trade Rep of intimidating Colombia over Novartis patent

May 25, 2016 - Letter from WHO to Colombia Clarifying Right to Issue Compulsory Licenses

May 25, 2016 - Rep. Levin Press Release: House Democrats Press USTR to Clarify Position on Compulsory Licensing for Generic Medicines in Colombia (see the letter here)

May 25, 2016 - Knowledege Ecology International: WHA 69: Colombian Minister of Health Calls on WHO to Support Sustainable Model for Health, Regulation of Monopolies

May 23, 2016 - Pronunciamiento de la Conferencia Episcopal sobre el proceso de declaratoria de existencia de razones interés público con efectos de licencia obligatoria para el Imatinib

May 21, 2016 - Salt Lake City Tribune: Op-ed: Hatch puts Colombian peace at risk to help Novartis

May 20, 2016 - Wall Street Journal: Colombia Threatens to Override Novartis’s Patent on Gleevec

May 19, 2016 - Letter: Public Citizen Joins Knowledge Ecology International, Oxfam America and Health GAP in Writing to Senator Hatch Regarding Reported Pressure On Colombia Not to License Cancer Medicine Glivic

May 18, 2016 - Washington Post: Dispute with Swiss drugmaker has Colombian officials worried about U.S. peace funding

May 18, 2016 - Press Release: Groups Warn Against Senate HELP Committee Members’ Legislative Sleight of Hand on Cures Act

May 18, 2016 - STAT: Colombia to Novartis: Lower the price of your cancer drug, or else

May 18, 2016 - Reuters: Deal still possible in Colombia-Novartis cancer drug talks : minister

May 17, 2016 - El Espectador: Bernie Sanders acusa a Oficina de Comercio de EE.UU. de presionar a Colombia en caso imatinib

May 17, 2016 - Letter from more than 120 Academics and Advocates to President Santos of Colombia Affirming Colombia's Right to Issue a Compulsory License on Cancer Medicine Imatinib (marketed by Novartis under the brand name Glivec)

May 16, 2016 - El Espectador: Expertos apoyan decisión de Minsalud de reducir precio del Imatinib, medicamento para el cáncer

May 12, 2016 - Washington Post: A simple way for the government to curb inflated drug prices

May 12, 2016 - STAT: Colombian health minister is warned not to sidestep Novartis patent

May 11, 2016 - Huffington Post: Colombia Fears U.S. May Reject Peace Plan To Protect Pharma Profits

May 10, 2016 - Counter Punch: From Cancer Patient to Medicines Activist

May 10, 2016 - The Caravan: What Happened to the Indian Official that Rejected the US Drug Company Gilead’s Patent Application in 2015

May 10, 2016 - El Espectador: Las presiones de EE.UU. para que Colombia no regule el precio del imatinib

April 28, 2016 - Swiss Broadcasting Corporation - Colombian minister proposes ending Novartis patent

April 26, 2016 - Statement: Gilead’s Earnings Are Based on Price Gouging Hepatitis C Treatments

April 26, 2016 - Fort Erie Times: Niagara company offers U.S. cheaper cancer drug

April 26, 2016 - The Inter-American Dialogue's daily Latin American Advisor -- Q&A with Public Citizen's Peter Maybarduk

April 12, 2016 - Common Dreams: Think Medicine is Expensive Now? Public Health Groups Warn of TPP's Gifts to Big Pharma

April 12, 2016 - The Hill: Public health groups call for Congress to reject TPP

April 12, 2016 - NGO Letter to Congress Calling for Rejection of TPP Due to Concerns over Public Health Impacts

April 12, 2016 - Washington Post: More than 50 health, religious and labor groups urge Congress to reject TPP trade deal

April 6, 2016 - Huffington Post: Rx for Outrageous Drug Prices: Heal Our Democracy (authored by Public Citizen President Robert Weissman)

April 5, 2016 - Public Citizen Testimony re: Vermont H.866 – "An act relating to prescription drug manufacturer cost transparency", Delivered by Steven Knievel before the House Committee on Health Care of the Vermont House of Representatives

April 1, 2016 - Telemundo: Protestan contra inflación de precios de medicinas

April 1, 2016 - The Body: Chanting 'Pharma Greed Kills,' HIV and Health Justice Groups Protest Across Time Zones and Continents

March 31, 2016 - Report from Public Citizen's Health Research Group: Twenty-Five Years of Pharmaceutical Industry Criminal and Civil Penalties: 1991 Through 2015

March 21, 2016 - Public Citizen and Non-Profit Groups Urge Obama Administration, NIH to Lower Price of Publicly-Funded, $129,000 Per Year Prostate Cancer Drug

March 1, 2016 - Ministry of Health Resource Page on Imatinib Compulsory License Request

February 27, 2016 - Submission of Health GAP to the United Nations Secretary-General's High-Level Panel on Access to Medicines, co-authored by Public Citizen

February 26, 2016 - Submission of Public Citizen to the United Nations Secretary-General's High-Level Panel on Access to Medicines

February 24, 2016 - Kentucky Center for Investigative Reporting: Drug Company Lobbying Has Doubled In Kentucky In Recent Years

February 18, 2016 - Public Citizen, Health Action International & Commons Network Position Statement on TTIP and Access to Medicines -- available in Spanish here

February 17, 2016 - Technical Committee Declares Cancer Medicine Imatinib (Glivec) to be of Public Interest, Paving Way for a Compulsory License

February 11, 2016 - plus: Is There Still Time to Stop This Threat to the Global HIV Effort?

February 6, 2016 - Scrips Howard: Protesters Say Medicines Will be Unaffordable with TPP

February 6, 2016 - Video: Cancer Patients Arrested at World Cancer Day Protest

February 5, 2016 - Public Citizen Comments for USTR's 2016 Special 301 Review

January 1, 2016 - Modern Healthcare: High drug prices will be a big political issue in 2016

December 19, 2015 - New York Times Editorial Board: No Justification for High Drug Prices

December 17, 2015 - StatNews: For drug companies, the Martin Shkreli nightmare isn't over yet

December 17, 2015 - AP: Exec who jacked up price of a lifesaving drug is arrested

December 16, 2015 - In These Times: 8 Terrible Things About the Trans-Pacific Partnership

December 14, 2015 - House “Orphan” Drug Law Proposal Criticized In Public Citizen Report

December 9, 2015 - Public Citizen Health Advocate Vijay Das on CNN: Congress, don't fall for Big Pharma's gimmick

December 9, 2015 - Wall Street Journal: How Pfizer Set the Cost of Its New Drug at $9,850 a Month

December 8, 2015 - StatNews' Pharmalot: Bill creating more orphan drugs would cost taxpayers and patients

December 8, 2015 - Regulatory Affairs Professional Society: Consumer Advocacy Group Warns on Orphan Provisions in 'Cures' Act

December 8, 2015 - Wall Street Journal: 5 Things to Know About How Drug Prices Are Set

December 8, 2015 - Press Release: Orphan Medication Proposal: A Windfall for Pharma, False ‘Cure’ for Patients

December 8, 2015 - Video: Public Citizen's Maybarduk Testifies at the House Ways & Means Democrats' Hearing on the TPP and Access to Medicines

December 8, 2015 - Public Citizen Testimony Before House Committee on Ways and Means Democrats' Hearing on the Trans-Pacific Partnership and Access to Medicines

December 1, 2015 - Washington Post: How an $84,000 drug got its price: ‘Let’s hold our position … whatever the headlines’

November 28, 2015 - The Economist: Billion-dollar babies

November 26, 2015 - The Salt Lake Tribune: Once an Obama ally on trade deal, Utah’s Hatch may fight latest proposal

November 25, 2015 - CBS News: Turing cuts 5,000% drug price hike to 2,500%

November 25, 2015 - Factsheet: How the TPP Endangers Access to Affordable Medicines (updated November 2015)

November 25, 2015 - Memo: TPP vs. Access to Medicines in Developing Countries; TPP Rolls Back “May 10th Agreement” Reforms (updated November 2015)

November 25, 2015 - Memo: Three Burning Questions about the TPP Transparency Annex and Its Implications for U.S. Health Care (updated November 2015)

November 19, 2015 - Memo: Ambiguity Leads to Fallacy: Biologics Exclusivity in the Trans-Pacific Partnership (updated November 2015)

November 16, 2015 - Memo: TPP Transition Periods: Bad Rules Comming Soon in a TPP Country Near You (updated November 2015)

November 5, 2015 - Memo: The Highlights of the Trans-Pacific Partnership E-commerce Chapter (coauthored with Tamir Israel of Canadian Internet Policy & Public Interest Clinic -- CIPPIC)

November 5, 2015 - Press Release: TPP Text Reveals Risk for Consumer Privacy Reform

October 9, 2015 - Public Citizen Analyses of Final Text of TPP IP Chapter Published by WikiLeaks

October 6, 2015 - Science Mag: Trade agreement praised and panned

October 6, 2015 - Democracy Now on the TPP with segments featuring Public Citizen President Robert Weissman and Affordable Cancer Medicine Activist Zahara Keckscher

October 5, 2015 - Marketplace: In the end, the real hurdle to a TPP deal was drugs

October 5, 2015 - Vox: How the Trans-Pacific Partnership could drive up the cost of medicine worldwide

October 5, 2015 - NPR: This We Do Know About TPP: The Shouting Is Already Loud

October 5, 2015 - What Changes Lie Ahead From the Trans-Pacific Partnership Pact

October 5, 2015 - Statement: Eleventh Hour #TPP Deal on Biotech Drugs Still Harms Access to Medications

October 4, 2015 - New York Times: As Pacific Trade Negotiators Haggle, U.S. Officials Remain Hopeful

October 4, 2015 - Wall Street Journal: U.S., Australia Agree on Complicated Compromise on Biologic Drugs

October 3, 2015 - Washington Post: Fierce split over next-generation drugs holds up Pacific Rim trade talks

October 3, 2015 - New York Times: Negotiations on Trans-Pacific Trade Pact Are Extended, Fueling Hope

October 2, 2015 - Los Angeles Times: Trade talks over Pacific Rim deal appear headed to a third day

October 2, 2015 - Letter from Members of Congress to Froman Asking USTR to Support LDC TRIPS Transition Period Extension

October 1, 2015 - The Malaysian Insider: TPP trade talks narrow on tough auto, drug, dairy issues

October 1, 2015 - Wall Street Journal: Rift Over Drug Protections Complicates Trans-Pacific Partnership Trade Talks

October 1, 2015 - Japan Times: Ministerial TPP talks kick off, with nations far apart on drug patents

October 1, 2015 - AARP: Latest TPP Biologics Proposal Is a Step in the Wrong Direction

October 1, 2015 - MintPress News: Protesting Big Pharma ‘Death Sentence,’ Cancer Patient Arrested Outside TPP Talks

September 30, 2015 - New York Times: Pacific Trade Deal Talks Resume, Under Fire From U.S. Presidential Hopefuls

September 28, 2015 - Memo: New TPP Maneuvering on Biotech Drugs: 5+3 Still Makes 8

September 18, 2015 - IP Watch: Health Advocates Press United States On WTO LDC IP Waiver

September 17, 2015 - IP Watch: Inside Views: The Lexmark Litigation: Why Does Big Pharma Care So Much About Ink Cartridges?

September 11, 2015 - Public Citizen & NGOs in Letter to USTR & USPTO Regarding WTO LDC Members' Request for an Extension of their Pharmaceutical Transition Period

September 3, 2015 - Baltimore Sun: Public health advocates call on Johns Hopkins to make TB drug widely available

September 2, 2015 - New York Times Editorial: Costly Hepatitis C Drugs for Everyone?

September 1, 2015 - The Hill: Sanders to introduce bill targeting high drug prices

August 27, 2015 - Entrevista a Mario Rios de Justicia en Salud en el programa Exitosa Noticias

August 27, 2015 - Entrevista a Mario Rios de Justicia en Salud en el programa San Borja Noticias

August 22, 2015 - La Republica: PJ ordena al Minsa informar sobre licencia para Atazanavir

August 20, 2015 - Journal of the American Medical Association: The Trans-Pacific Partnership Agreement and Implications for Access to Essential Medicines

August 18, 2015 - IP Watch: Inside Views: Five Reasons Why TPP Countries Should Unite To Oppose The US Pharmaceutical IP Agenda

August 14, 2015 - Colombia - Acta de no acuerdo Solicitud de licencia voluntaria con Novartis, en español

August 12, 2015 - Ending AIDS by 2030: Challenges and Opportunities

August 12, 2015 - Clinical Infectious Diseases: Access to Costly New Hepatitis C Drugs: Medicine, Money, and Advocacy

August 11, 2015 - Public Citizen Comments to the Office of the U.S. Trade Representative RE: USTR-2015-0009 South Africa AGOA Eligibility (post-hearing)

August 8, 2015 - The Lancet: The Vancouver Consensus: antiretroviral medicines, medical evidence, and political will

August 6, 2015 - Public Citizen Comments to the Office of the U.S. Trade Representative RE: USTR-2015-0009 South Africa AGOA Eligibility

August 4, 2015 - CitizenVox: How Much Is Enough for Gilead?

August 4, 2015 - Vox: One sentence that explains why Obama is struggling to finish his big trade deal

August 3, 2015 - New York Times: Trans-Pacific Partnership Session Ends With Heels Dug In

August 3, 2015 - Journal of Law, Medicine & Ethics: Antibiotic Resistance Is a Tragedy of the Commons That Necessitates Global Cooperation, by Aidan Hollis and Peter Maybarduk

August 1, 2015 - Al Jazeera English: Pacific trade officials fail to agree on final TPP deal

July 31, 2015 - Bloomberg: U.S. Said to Drop 12-Year Lock-Up on Biologics Data in TPP Talks

July 31, 2015 - Reuters: Consumer group warns of drug monopoly under TPP

July 31, 2015 - Bloomberg: U.S. Bends on Patent Data as Dairy Vexes Pacific Trade Talks

July 31, 2015 - Reuters:Pacific trade negotiators chase elusive final deal in tough talks

July 30, 2015 - Al Jazeera America: Trade deal threatens affordable healthcare for millions, experts say

July 30, 2015 - Global Post: Protesters blow conch shells to demonstrate against TPP trade deal in Maui

July 30, 2015 - Center for American Progress: Pharmaceutical Provisions of the Trans-Pacific Partnership Threaten Drug Access and Affordability

July 30, 2015 - Huffington Post - Expanding Medicare System for All Would Eliminate Health Care Rationing (authored by Public Citizen President Robert Weissman)

July 29, 2015 - GPhA & AARP in Huffington Post: TPP Threatens Access to Affordable Medications for People Around the World

July 29, 2015 - Public Citizen Report: Additional Exclusivity for Biologic Drugs in the TPP: A Need or Greed?

July 28, 2015 - Bloomberg: Drug patent dispute emerges as hurdle to Pacific trade deal

July 28, 2015 - Letter from Rep. Himes to Ambassador Froman Calling for TPP IP Provisions to Balance Innovation and Access to Medicines

July 28, 2015 - Bloomberg: Pacific Trade Talks Start With U.S. Vow to Solve Toughest Issues

July 28, 2015 - UNAIDS calls on trade negotiators to uphold governments’ commitments to public health and access to medicines

July 27, 2015 - AARP to Ambassador Froman: Don’t let the Trans-Pacific Partnership Restrict Access to Affordable Medicine

July 27, 2015 - IP Watch: Decision Time On Biologics Exclusivity: Eight Years Is No Compromise

July 24, 2015 - Office of Senator Sherrod Brown: In Advance of Latest Round of TPP Negotiations, Sen. Brown Raises Concerns Over Intellectual Property Chapter and Access to Medicines

July 23, 2015 - Letter from 11 members of Congress to USTR on the Trans-Pacific Partnership (TPP) and Access to Medicines

July 23, 2015 - New York Times: Drug Prices Soar, Prompting Calls for Justification

July 17, 2015 - El Comercio: La salud pública bajo amenaza, por Judit Rius Sanjuan

July 14, 2015 - La Republica: Licencia obligatoria hubiera permitido 75% de ahorro en Atazanavir

July 14, 2015 - Journal of the American Medical Association: Senator Urges VA to “Break” Patents for High-Cost Hepatitis C Drugs

July 13, 2015 - Foreign Affairs: The TPP's Bad Medicine

July 13, 2015 - La Republica: Bristol rebaja en 35% precio de fármaco contra el VIH, pero no deja el monopolio

July 13, 2015 - Bolsamania: Antirretroviral Atazanavir cuesta 35% menos hoy que ayer pero aún es muy caro en Perú

July 10, 2015 - Bloomberg: Obama Pushes Trade Partners to Add Drug Rules He Opposes in U.S.

July 8, 2015 - IP Watch: TISA Stocktaking Meeting Also Might Have To Face Growing Protests

July 7, 2015 - Forbes: TPP Still Has A Long Way To Go

July 2, 2015 - Ars Technica: WikiLeaks drops new set of secret TISA docs: Yep, no one agrees

July 2, 2015 - Analysis: Leaked TISA Annex on Electronic Commerce (Burcu Kilic, Public Citizen & Tamir Israel, Canadian Internet Policy & Public Interest Clinic)

July 1, 2015 - Politico: Leaked: What's in Obama's trade deal

June 25, 2015 - Wall Street Journal: Fast-Track’s Passage Sets Up Round Two on Obama’s Trade Agenda

June 24, 2015 - New York Times: President Obama Must Use Trade Authority to Reach Better Agreements

June 24, 2015 - Politico: Trade talks approach endgame with fast track passage

June 24, 2015 - Financial Times: Obama’s big Pacific trade gambit: What comes next

June 23, 2015 - Letter from Alianza in support of Ecuador’s proposed Law on the Social Economy of Knowledge (COESC)

June 19, 2015 - Wall Street Journal: Will the controversial Trans-Pacific Partnership trade agreement really be bad for your health?

June 19, 2015 - Financial Times: Congress’s fast track to discord on free trade

June 18, 2015 - Health and Human Rights Journal: The Trans-Pacific Partnership and Access to Medicines

June 18, 2015 - Wall Street Journal: House Passes Fast-Track Trade Bill

June 16, 2015 - New York Times: House Moves to Delay Action on Trade Bill for 6 Weeks

June 15, 2015 - Washington Post: US fast-track vote leaves Pacific trade pact talks in limbo

June 12, 2015 - Healthline: Would the Trans Pacific Partnership Boost Drug Prices and Endanger Access?

June 12, 2015 - Bloomberg: Rep. Levin: U.S. Trade Policies Aren't on the Right Track

June 12, 2015 - Public Citizen's Global Access to Medicines Program in The Hill: Leaks show trade deal undermines Obama's proposed healthcare reforms

June 11, 2015 - plus: People With HIV May be the Biggest Losers Under New Trade Treaty

June 11, 2015 - Public Citizen's Global Access to Medicines Program Director Peter Maybarduk on Democracy Now: Backlash Against TPP Grows as Leaked Text Reveals Increased Corporate Control of Public Health

June 10, 2015 - La Republica: Perú perderá soberanía en salud y se expondrá a juicios de farmacéuticas

June 10, 2015 - Memo: Three Burning Questions about the Leaked TPP Transparency Annex and Its Implications for U.S. Health Care

June 10, 2015 - Press Release: Latest TPP Leak Raises Burning Questions About Implications for U.S. Health Care System

June 10, 2015 - New York Times: U.S. Shifts Stance on Drug Pricing in Pacific Trade Pact Talks, Document Reveals

June 10, 2015 - WikiLeaks: TPP Transparency Chapter: Annex on Transparency and Procedural Fairness For Pharmaceutical Products and Medical Devices

June 10, 2015 - MarketPlace: What Big Pharma wants from the big trade deal

June 10, 2015 - Perú perderá soberanía en salud y se expondrá a juicios de farmacéuticas

June 5, 2015 - IP Watch: Confidential USTR Emails Show Close Industry Involvement In TPP Negotiations

May 28, 2015 - Rep. Sander Levin: Is TPP the Most Progressive Trade Agreement in History? Not If You Need Access to Affordable Medicines

May 27, 2015 - Financial Times: Free Lunch: Trans-Pacific opacity

May 27, 2015 - The Guardian: Here’s how much corporations paid US senators to fast-track the TPP bill

May 27, 2015 - New York Times: H.I.V. Treatment Should Start at Diagnosis, U.S. Health Officials Say

May 26, 2015 - The Washington Times: Obama’s Asia trade deal faces mounting opposition in House

May 22, 2015 - Paul Krugman in the New York Times: Trade and Trust

May 21, 2015 - Wall Street Journal: Bristol-Myers Faces a Compulsory License for an AIDS Drug in Peru

May 20, 2015 - MedPage Today: Could Trans-Pacific Partnership Place Drugs Out of Reach?

May 18, 2015 - Letter from Joseph Stiglitz to Members of Congress: Where Progressive and Conservatives Agree on Trade: Current Investor-State Dispute Settlement model is bad for the United States

May 13, 2015 - Financial Times: Senate compromise gives Obama ‘fair’ Pacific trade deal

May 12, 2015 - New York Times: Senate Democrats Foil Obama on Asia Trade Deal

May 12, 2015 - Sanders Urges VA to Use Emergency Powers to Save Lives of Veterans with Liver Disease (Press Release from Office of Sen. Sanders; see the letter from Sen. Sanders to Sec. McDonald here)

May 12, 2015 - Global Post: This US-backed Pacific trade deal could stop the poor from getting life-saving meds

May 8, 2015 - amfAR: Trans-Pacific Partnership: Curbing Access to Medicines Now and in the Future

May 5, 2015 - Memo: Accion Judicial de Bristol-Myers Squibb Respecto al Atazanavir

May 5, 2015 - New York Times Editorial: Runaway Drug Prices

April 28, 2015 - Public Citizen and IFARMA letter to INDECOPI on compulsory licensing

April 28, 2015 - Civil society letter to Peruvian officials on atazanavir compuslory license (available in English here)

April 28, 2015 - Academics letter to Peruvian officials on atazanavir compuslory license (available in English here)

April 24, 2015 - IP Watch: Inside Views: Divide And Conquer: The New US Strategy To Disentangle The TPP Negotiations

April 22, 2015 - New York Times: Newt Gingrich: Double the N.I.H. Budget

April 21, 2015 - Statement: California Legislature Should Pass Bill Requiring Greater Transparency from Pharmaceutical Companies

April 14, 2015 - Letter: Knowledge Ecology International and Public Citizen ask the NIH for safeguards in patent license for HCV drug

April 10, 2015 - Public Citizen in the Harvard Human Rights Journal: Freeing Trade at the Expense of Local Crop Markets?: A Look at the Trans-Pacific Partnership’s New Plant-Related Intellectual Property Rights from a Human Rights Perspective

April 9, 2015 - Public Citizen's Burcu Kilic and Pablo Viollier in El Mostrador: Opinión: Divide y vencerás, la nueva estrategia de Estados Unidos para destrabar las negociaciones del TPP (en español)

April 8, 2015 - Public Citizen in the Yale Journal of International Law: What Is Patentable Under the Trans-Pacific Partnership? (full article)

March 30, 2015 - Investor-State Attacks on Public Interest Policies: Access to Medicines; ISDS: Enforcer for Big Pharma Wish List; Health at Stake

March 27, 2015 - amfAR: The High Cost of Free Trade for People Living with HIV in the Asia-Pacific

March 25, 2015 - The New York Times: Trans-Pacific Partnership Seen as Door for Foreign Suits Against U.S.

March 25, 2015 - The Financial Times: The flaws in the geopolitical case for the TPP

March 20, 2015 - Coalition Statement: EU trade secrets directive threat to health, environment, free speech and worker mobility

March 11, 2015 - Krugman in the New York Times: TPP at the NABE

March 6, 2015 - Rep. Jan Schakowsky & Public Citizen's Global Access to Medicines Director Maybarduk in The Hill: US trade policy could raise drug prices, at home and abroad

March 5, 2015 - ANEPI interview with Global Access to Medicines Program Director Peter Maybarduk; "Licencias obligatorias no deben ser controversiales"

March 2, 2015 - New York Times Editorial: Congress’s Critical Role on Trade

February 17, 2015 - Interfaith Working Group on Trade letter urging Congress to oppose Fast Track

February 13, 2015 - The Star Online: Malaysian, other health professionals fear higher health cost after Pacific pact

February 12, 2015 - Reuters: Doctors warn of healthcare impact from Pacific trade pact

January 30, 2015 - Joseph Stiglitz in the New York Times: Don't Trade Away Our Health

January 26, 2015 - Public Citizen Global Access to Meds in the New York Times: Contrasting Perspectives on the Price of Medicines

January 25, 2015 - Public Citizen and Others in Letter to Obama: Promote Health In India Not Narrow Pharma IP Interests (links to

December 18, 2014 - Public Citizen Report: Competition Inhibitors: How Biologics Makers Are Leveraging Political Power to Maintain Monopolies and Keep Prices Sky-High

Read the press release on the report here

December 17, 2014 - Press Release: Leak of Obama Administration Trade Pact Proposal Reveals Negotiations Affecting Net Neutrality, Limits on Data Privacy Protections

December 17, 2014 - Report: Proposal of New Provisions Applicable to All Services of the secret TISA negotiations

December 17, 2014 - Coalition Statement: EU trade secrets directive threat to health, environment, free speech and worker mobility (updated March 20, 2015)

December 3, 2014 - Press Release: Government Action Needed to Slash Prices for Hepatitis C Treatments
Read the testimony from Public Citizen President Rob Weissman here.

November 17, 2014 - Letter sent to President Ollanta Humala of Peru requesting a compulsory license on the HIV medication atazanavir in Peru

November 17, 2014 - Letter sent to Ministry of Health of Peru requesting a compulsory license on the HIV medication atazanavir in Peru

October 16, 2014 - Public Citizen analyses of the new WikiLeaks TPP IP text

October 2, 2014 - Public Citizen Chart summarizing history of compulsory licensing in Ecuador

September 2, 2014 - One Step Forward, One Step Back – Ecuador issues new, pro-health compulsory licenses, but signs harmful trade agreement with the European Union (available in Spanish here)

August 14, 2014 - - Sobregasto en medicamentos (en español)

July 17, 2014 - NPR: Evaluating The Benefits And Costs Of Patents (links to

July 15, 2014 - Livemint: Bombay HC upholds Nexavar compulsory licensing decision (links to

July 14, 2014 - MSF: TPP: Still a Terrible Deal for Poor People's Health(links to

July 7, 2014 - Op-ed: The TPP could be a blow to public health (links to

June 25, 2014 - Video of Global Access to Medicines Program Director Peter Maybarduk's presentation at the Transatlantic Consumer Dialogue event on IP in TAFTA

June 23, 2014 - Videos, summaries, photos and more from the June 5 briefing on the Eli Lilly v. Canada investor-state case and secondary pharmaceutical patents

May, 2014 - Presentation: Confidential Commercial Information vs. Our Right to Know

May 27, 2014 - CitizenVox: Public Citizen Joins Partners in Calling for Action Against Antibiotic Resistance

May 25, 2014 - Public Citizen News: Working for Big Pharma: U.S. Government Pressures Developing Countries

May 22, 2014 - Public Citizen and members of the Antibiotic Resistance Coalition calls on World Health Organization Member States to pass critical resolution

Learn more about antibiotic resistance and the Antibiotic Resistance Coalition's work.

May 15, 2014 - Boehringer Ingelheim's response to Public Citizen's letter regarding the Medicines Patent Pool

See our Medicines Patent Pool resource page for more resources.

May 1, 2014 - The Times of India: Ten emerging economies targeted by US for IP violation, India’s inclusion widely criticized

May 1, 2014 - The Economic Times: US not placing India under the punitive Priority Foreign Country most sensible thing to do: Experts

May 1, 2014 - The Economic Times: Did US baulk at prospect of upsetting the next government on IPR?

May 1, 2014 - SpicyIP: Special 301 Report: India not downgraded to Priority Foreign Country, will receive OCR though

April 30, 2014 - Infojustice: USTR Avoids India’s WTO Threats to Special 301

April 30, 2014 - Statement: U.S. Chamber, Big Pharma Miss Their Target on India Trade, But U.S. Watch List Still Bullies India, Other Developing Countries Over Health Policies

See more about U.S. pressure against countries' public interest policies.

April 29, 2014 - Truthout: Hand in Hand With US Government, Big Pharma Pushes for More Profits

April 25, 2014 - Novartis' response to Public Citizen's letter regarding the Medicines Patent Pool

April 23, 2014 - Johnson & Johnson's response to Public Citizen's letter regarding the Medicines Patent Pool

See our Medicines Patent Pool resource page for more resources.

April 18, 2014 - Presentation at Johns Hopkins Bloomberg School of Public Health: Ensuring Safety and Access, or Thinking Usefully About Counterfeits

April 17, 2014 - Peruvian Civil Society Organizations Demand that Government Issue a Compulsory License for Atazanavir (links to

April 15, 2014 - Business Standard: Indian laws should not be considered discriminatory: Group (links to

April 11, 2014 - Public Citizen Comments to the United States International Trade Commission Re: Investigation No. 332-543, Trade, Investment, and Industrial Policies in India: Effects on the U.S. Economy

April 8, 2014 - Public Citizen letters to AbbVie, Boehringer-Ingelheim, Bristol-Myers Squibb, F. Hoffman-La Roche, Gilead, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Pfizer and Shionogi regarding the latest licensing agreement between ViiV Healthcare and the Medicines Patent Pool

See our Medicines Patent Pool resource page for more statements.

April 8, 2014 - Rep. Raul Grijalva and Global Access to Medicines Program Director Maybarduk in the Huffington Post: The Trans-Pacific Partnership Is terrible for Public Health (links to

April 1, 2014 - Medicines Patent Pool-ViiV Healthcare Licensing Agreement Statement of Peter Maybarduk, Global Access to Medicines Program Director

See our Medicines Patent Pool resource page for more statements.

March 31, 2014 - Public Citizen's Global Access to Medicines Program letter to the editor of the New York Times: How Public Research Underpins Private Health Care (links to

March 20, 2014 - Letter from members of Congress requesting Gilead CEO to justify pricing of Hepatitis C drug Solvadi

March 14, 2014 - 16 members of Congress write USTR expressing concern over TPP provisions' effect on access to medicines

March 14, 2014 - Sunlight Foundation: How Big Pharma (and others) began lobbying on the Trans-Pacific Partnership before you ever heard of it

February 27, 2014 - Krugman NYT Op-ed: No Big Deal (links to

February 24, 2014 - Public Citizen Comments for USTR's 2014 Special 301 Review. See the video of Global Access to Medicines Program Director Peter Maybarduk's testimony here.

February 24, 2014 - BBC: US-India relations suffer in trade spat over cheap drugs (links to

February 12, 2014-Coalition Statement: Access to medicines coalition takes a joint stance against USTR's "new" approach for addressing access to medicines in developing countries in the TPP

February 11, 2014 - National Journal: The Last Major Fault Line in the Democratic Party (links to

February 10, 2014 - New York Times: Poor Nations Seek New Hepatitis C Drug (links to

February 5, 2014 - AIDS Activists say Merck walking all over South Africans for profit (links to

February 4, 2014 - BBC: Do drugs really have to be so expensive? (links to

January 27, 2014 - Health Affairs Blog: Don't put the brake on ending AIDS (links to

January 17, 2014 - Several ranking members in Congress send letter to USTR in support of access to medicines in developing countries

January 17, 2014 - Mail and Guardian: Motsoaledi: Big pharma's 'satanic' plot is genocide (links to

January 16, 2014 - The Guardian: South African pharma firms accused of planning to delay patents law reform (links to

January 11, 2014 - HuffingtonPost: Why House Democrats Might Kill Obama's Big Trade Deal (

January, 2014 - Updated Analysis: Dangers for Medicine Prices and Local Innovation in the Trans-Pacific Partnership Agreement (TPP): Comparative Analysis of the United States' Intellectual Property Proposal and Japanese Law, Dr. Burcu Kilic, Mi Kyoeng Kim & Peter Maybarduk, January 2014

December 23, 2013 - The Pharma Letter: Ukraine government introduces compulsory licensing for pharma products (links to

December 18, 2013 - Washington Post: Obama administration sued over its secretive trade negotiations (

December 12, 2013 - Medicines Patent Pool Reaches Licensing Deal with BMS to Expand Access to AIDS drug (links to

December 9, 2013 - KEI: 6 Members of Congress Write to President Obama on TPP and Access to Health Care, Criticize Closed Door Negotiations (links to

December 9, 2013 - KEI: 29 Organizations and More than 70 Individuals Sign Letter Opposing Life Plus Seventy Year Copyright Term in TPP (links to

December 6, 2013 - Representative Waxman sends letter to USTR expressing strong disagreement with 12 years of data exclusivity in the TPP (links to

December 5, 2013 - Vatican criticizes TRIPS+ and ISDS provisions in FTAs at WTO Ministerial Conference (links to

November 27, 2013 - US's Proposed TPP Transition Period for Middle-Income Parties is Fools Gold (links to

November 26, 2013 - Washington Post: Here's why Obama trade negotiators push the interests of Hollywood and drug companies (links to

November 24, 2013 - The Globe and Mail: Canada must learn from NAFTA legal battles (links to

November 24, 2013 - Scoop: Outrageous US bullying on IP and Health at TPPA Talks (links to

November 19, 2013 - Congresswoman Barbara Lee Hails Passage of Bipartisan PEPFAR Stewardship Act (links to

November 19, 2013 - Financial Times: Global spending on drugs to exceed $1tn (links to

November 18, 2013 - Desmond Tutu in Politico: Two Steps Obama Can Take to Defeat AIDS (links to

November 13, 2013 - Public Citizen: Leaked Documents Reveal Obama Administration Push for Internet Freedom Limits, Terms That Raise Drug Prices in Closed-Door Trade Talks

November 13, 2013 - NYTimes: House Stalls Trade Pact Momentum (links to

November 12, 2013 - Pharmalot: What Patent Reform in Brazil and South Africa Can Mean (links to

November 9, 2013 - PBS: Maine's Prescription for drug savings: Go foreign

November 8, 2013 - Eyes on Trade: 38 Million Retirees Join Workers and Consumers to Say No to "Trade" Deal Terms that Would Make Medicine More Expensive

November 8, 2013 - Counter Punch: The Withering of Big Pharma?

November 7, 2013 - Knowledge Ecology International: NIH rejects March-In petition, also rejects proposed rules on pricing of and access to government funded inventions

November 3, 2013 - Naked Capitalism: The Global Corporatocracy is Almost Fully Operational

October 28, 2013 - PAHO: Countries of the Americas choose innovative projects for the development of drugs and technologies

October 21, 2013 - Reuters: Ending drug trial secrecy is a boon for R&D, says EU agency

October 11, 2013 - The Hindu Business Line: What the Doctor Ordered

October 10, 2013 - The Hill: Drug makers try to outflank White House in trade agreement

October 9, 2013 - Dissent: Patents Against People How Drug Companies Price Patients out of Survival

September 26, 2013 - Politico: President Obama to dive into Pacific trade talks

September 21, 2013 - The Post Online: Lack of access to essential medicines, new technologies worries Ban

September 12, 2013 - Politico: Eli Lilly sues Canada on drug patents

September 9, 2013 - WUNC:Duke Institute Looks for New Ideas in Access to Medicine

August 29, 2013 - The New York Times: The Hazard of Free-Tr

August 23, 2013 - The New York Times: Why is Obama Caving on Tobacco? (links to

July 29, 2013 - The New England Journal of Medicine: Engineered in India - Patent Law 2.0 (links to

July 14, 2013 - The New York Times: How Intellectual Property Reinforces Inequality (links to

July 12, 2013 - Patrick Leahy: Leahy Urges Action To Ensure Access To Affordable Life-Saving Diagnostic Tests For Breast And Ovarian Cancer (links to

July 11, 2013 - U.S. PIRG: Top Twenty Pay-For-Delay Drugs (links to

July 8, 2013 - Citizen Vox: Public Citizen welcomes the Marrakesh Treaty for the Blind (links to

June 28, 2012 - Global Post: Historic Treaty Signed Giving Blind Better Books Access (links to

June 27, 2013 - Public Citizen: India's Patent System Plays by WTO Rules and Supports Global Health (links to

June 19, 2013 - Citizenvox: Reversing the "IP Ratchet : Global Implications of the U.S. Supreme Court's Ruling in Myriad (links to

June 18, 2013 - Huffington Post: Alan Grayson on Trans-Pacific Partnership: Obama Secrecy Hides 'Assault on Democratic Government' (links to

June 10, 2013 - The Guardian: Poorest countries eye additional grace period on intellectual property issues (links to

June 10, 2013 - The Guardian: Poorest countries eye additional grace period on intellectual property issues (links to

June, 2013 - International Centre for Trade and Sustainable Development: El Acuerdo de Asociación Transpacífico en la política comercial chilena (links to

June 2, 2013 - Scoop: Chile's ex-chief negotiator drops a bombshell on TPPA (links to

June 2, 2013 - The New York Times: Obama's Covert Trade Deal (links to

May 30, 2013 - The Jakarta Globe: Future Hepatitis C Blockbusters May Spawn Compulsory Generics (links to the

May 23, 2013 - New Vision: Civil Society groups petition US, EU over WTO TRIPS Agreement (links to

May 20, 2013 - Huffington Post: TRIPS Exemption Opposed by Obama Administration, Threatening Cost Spike for Drugs in Poorest Nations (links to

May 18, 2013 - Huffington Post Canada: Why Are We Bullying the World's Poorest Countries? (links to

May 17, 2013 - Tech Dirt: Big Pharma Firms Seek .pharmacy Domain To Crowd Out Legitimate Foreign Pharmacies (links to

May 15, 2013 - The Atlantic: How Drug Companies Keep Medicine Out of Reach (links to

May 15, 2013 - Members of Congress urge USTR to support request from least developed countries for a TRIPS waiver extension

May 14, 2013 - The New Nation: US, EU urged to keep TRIPS waiver open (links to

May 12, 2013 - Slate: Gene patents: The case of Myriad Genetics shows the dangers of overly protecting intellectual property rights (links to

May 2, 2013 - CitizenVox: US Government's "Watch List" on Developing Countries Health Rights (links to

May 1, 2013 - The New York Times: Exorbitant Prices for Cancer Drugs (links to

April 25, 2013 - Blood Journal: Prices of drugs for chronic myeloid leukemia (CML), reflection of the unsustaintable cancer drug prices: perspective of CML experts (links to

April 25, 2013 - New York Times: Doctors Denounce Cancer Drug Prices of $100, 000 A Year (links to

April 23, 2013 - Wall Street Journal Op-Ed: Must All Patents Last for 20 Years? (links to

April 23, 2013 - Johnson & Johnson response to Public Citizen letter on the Medicines Patent Pool

April 22, 2013 - Bristol-Myers Squibb response to Public Citizen letter on the Medicines Patent Pool

April 2, 2013 - Public Citizen letters to Abbott Laboratories, Boehringer-Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Merck & Co. and Pfizer regarding the ViiV Healthcare and Medicines Patent Pool Agreement

April 1, 2013 - Analysis: India’s Supreme Court Upholds Strict Patent Standards and Patients’ Right to Access to Affordable Medicines; Court dismisses unmeritorious court challenge by drug giant

April 1, 2013 - Patent's defeat in India is Key Victory for Generic Drug

April 1, 2013 - Novartis Cancer-Drug Patent Denied by India Supreme Court

March 28, 2013 - BBC News: Do drugs really have to be so expensive? (links to

March 18, 2013 - Public Citizen press release: Winners of ACTA and SOPA Battles Call for Exclusion of 'Intellectual Property' From EU-U.S. Trade Talks

March 18, 2013 - Essential Inventions issues request for non-voluntary authorization to use patents under Article 14 of Greece patent law (links to

March 17, 2013 - The Nation: Avoid Mistakes of the West: Stiglitz (links to

March 17, 2013 - Bangkok Post: Stiglitz warns not to expect a quick global recovery (links to

March 8, 2013 - Third World Network: South Support LDCs' transition period, North creates obstacles (links to

March 4, 2013 - Doctors Without Borders Press Release: As Clock Ticks Towards Trans-Pacific Trade Pact Deadline, U.S. Must End Stall Tactics on Access to Medicines

March 4, 2013 - Wall Street Journal: India Appeals Body Rejects Bayer's Plea on Nexavar (links to

February 28, 2013 - -Info Justice: Detailed Analysis of the Medicines Patent Pool-- ViiV Pediatric ARV License and Memorandum of Understanding (links to

February 28, 2013 - HuffPost Live: Prescriptions to Die Live Segment, Featuring Global Access to Medicines Director Peter Maybarduk

February 28, 2013 - Press Release: Medicines Patent Pool Reaches Licensing Deal for GSK Patents to Expand Access to Medicines for Children with HIV

February 27, 2013 - Reuters: GlaxoSmithKline unit joins patent pool for AIDS drugs (links to

February 26, 2013 - KEI Online: The US Department of Justice and USPTO call for compulsory licenses on thousands of "standards-essential patents" (links to

February 6, 2013 - Huffington Post: Patent Reform, System Should Be Abolished, Fed Economists Say (links to

January 9, 2013 - Wall Street Journal: The TPP would be a bitter pill (links to

December 18, 2012 - Dawson Strat: The Problem of Patent Protection (links to

December 6, 2012 - Ars Technica: Staffer axed by Republican group over retracted copyright-reform memo (links to

December 5, 2012 - Open Society Foundations blog post by Access to Medicines Director Peter Maybarduk: Trans-Pacific Partnership: Closed Negotiations Against the Knowledge Economy

December 4, 2012 - Press Release: Digital Rights and Health Experts Frustrated by New Rule To Shut Out Civil Society from TPP Negotiation Venue

December 3, 2012 - Scoop: Press Release from Jane Kelsey: Lockout of Stakeholders from TPP Negotiations (links to

November 11, 2012 - Pharmac Annual Report: Pharmac says its work has saved district health boards more than $5 billion over the past 12 years

November 9, 2012 - Leesburg Patch: Letter to the Editor by Access to Medicines Director Peter Maybarduk: Medicines Monopoly (links to

November 5, 2012 - Irin News:South Africa: Easy patents cost patients (links to

November 2, 2012 - Press Release: Patients succeed in overturning first ever product patent on medicine in India (links to

October 30, 2012 - Knowledge Ecology International: How common is Federal Funding of patented inventions? (links to

October 25, 2012 - Knowledge Ecology International: Four NGOs ask NIH to grant open licenses to ritonavir patents under Bayh-Dole March-in provisions (links to

October 23, 2012 - ACLU: Get Ready for A Scintillating Discussion on the Finer Points of IP and Foreign Trade Policy (links to

October 14, 2012 - New York Times: In Cancer Care, Cost Matters (links to

October 11, 2012 - Press Release: Indonesian Government Takes Bold Stance to Reduce Costs of AIDS Medications, Potentially Saving Thousands of Lives (links to

October 11, 2012 - The Guardian: Indonesia in bold move to obtain cheap drugs for HIV (links to

October 9, 2012 - Wall Street Journal: Letter to the Editor by Global Access To Medicines Director, Peter Maybarduk: Compassion, Risk and IP Protection

September 26, 2012 - Public Citizen's Global Access To Medicine Program: Comparative Table of Patent Linkage Provisions in U.S. Free Trade Agreements and the U.S. Proposal to the Trans-Pacific (TPP) Agreement

September 6, 2012 - Amnesty International Press Release: TPP Must Not Trade Away Free Speech and Health (links to

September 6, 2012 - Wall Street Journal: TPP Too Secretive, Damaging to Digital Rights, Public Interest Groups Say (links to

September 5, 2012 - Telephone Briefing: What TPP Means for Digital Rights and Patients' Rights, listen to Public Citizen's Peter Maybarduk (2:26)

September 4, 2012 - Nature: Trade deal to curb generic-drug use (links to

August 29, 2012 - ACLU: The Biggest Threat to Free Speech and Intellectual Property That You've Never Heard Of (links to

August 28, 2012 - Civil Society Groups Oppose US and Australia's TPP Proposal on Exceptions and Limitations (links to

August 28, 2012 - The Wall Street Journal House Democrats Call On Administration To Open Trade Talks-Request Access as Observers to Trans-Pacific Partnership Negotiations

August 27, 2012 - The Guardian: The Pacific free trade deal that's anything but free (links to

August 24, 2012 - Public Knowledge & Public Citizen: Intellectual Property in the TPP: How About a Little Balance (links to

August 22, 2012 - Bangkok Post: Data exclusivity a life and death issue (links to

August 19, 2012 - Wall Street Journal: Novartis Fights India for Cancer Pill Patent (links

August 17, 2012 - The Hindu Business Line: Cipla bats for automatic compulsory licensing (link to

August 8, 2012 - Business Week: AIDS Sufferers Seen Hurt in Pacific Trade Pact Limits (links to

August 7, 2012 - Pfizer agrees to pay $15 million penalty to resolve foreign bribery investigation
Court DocumentsInformation | Deferred Prosecution Agreement

August 7, 2012 - Pharmalot: Malaysia Objects to Patent Terms in Trade Deal (links to

July 30, 2012 - Calling for an "AIDS free generation" but trading away our lives (links to Citizen News Service)

July 30, 2012 - The Most Important Trade Agreement That We Know Nothing About (links to Slate)

July 25, 2012 - Interview with Global Access to Medicines Program Director Peter Maybarduk (links to Radio Australia)

July 24, 2012 - Rep. Henry Waxman: More work needs to be done on HIV (links to Politico)

July 24, 2012 - International AIDS Conference Sparks Protest of Obama Trade Policies (links to Huffington Post)

July 23, 2012 - Press Release: Obama Trade Pact Could Impede "AIDS-free Generation"

July 22- 27, 2012- - The 19th International AIDS Conference in Washington D.C.

July 21, 2012 - We Can End AIDS: Join Us this Tuesday in Washington, D.C.

July 20, 2012 - Ending the HIV/AIDS Epidemic Act of 2012 Introduced; Aims to Protect Flexible IP Policies that Promote Access to Medicines (links to

July 19, 2012 - Thailand Urged to Reject Gilead AIDS Drug Patents (links to Pharmalot)

July 18, 2012 - Patents limiting access to anti-retroviral drugs used to treat HIV (links to The Global and Mail)

July 13, 2012 - Kaiser Family Foundation: Trade Agreements Could Harm Access To Antiretroviral Drugs In Asia, Pacific, Experts And Activists Warn

July 10, 2012 - HuffPo: Poison Pills, While Cutting Costs At Home, Obama Administration Pushes Higher Drug Prices On World's Poor (link to

July 2-10, 2012 - Round 13 of TPP negotiations in San Diego, CA, USA

June 29, 2012 - Joint Statement from Malaysian health advocacy groups against the Trans-Pacific Partnership Agreement

June 29, 2012 - Issa, Canada, and Mexico All Denied TPP Observer Status; Congress Continues to Seek Greater Transparency (links to

June 28, 2012 - Huff Po: In Other News, Obama Admin to Block Access to Affordable Cancer Drugs in Developing Countries (links to Huffington Post)

June 28, 2012 - Techdirt: Over 130 Representatives Spell Out their Concerns with TPP in Letter to Ron Kirk (links to Techdirt)

June 27, 2012 - Public Citizen Global Trade Watch's Lori Wallach: NAFTA on Steroids (links to The Nation)

June 27, 2012 - Press Release: Congressional Democrats Escalate Criticism of Substance, Process of Obama's 1st Trade Pact - the TPP

June 27, 2012 - With Proposed NAFTA-Style Trade Deal Threatening to Undermine American Auto and Manufacturing Jobs, Brown Joins Business & Labor Leaders to Announce Efforts to Reform Trade Agreements (links to Sherrod Brown Congressional Website)

June 25, 2012 - With Trans-Pacific Partnership Negotiations Set to Continue in California Next Week, Senators Call for Increased Transparency, Including Broader Consultation on Internet Freedom (links to Sherrod Brown Congressional Website)

June 21, 2012 - The Trans-Pacific Partnership: "Can you say 'Déjà vu' in Spanish?" (links to CitizenVox)

June 21, 2012 - BBC News: European trade committee votes to reject piracy treaty (links to BBC News)

June 20, 2012 - The Trans-Pacific Partnership: "Just Relax Canada, U.S. Pharma Will Handle It" (links to CitizenVox)

June 19, 2012 - USTR Kirk Welcomes Canada as New Trans-Pacific Partnership Negotiating Partner (links to

June 18, 2012 - USTR Kirk Welcomes Mexico as a New Trans-Pacific Partnership Negotiating Partner (links to

June 14, 2012 - While Battle against ACTA Rages, next Clash against TPP Looms (links to CitizenVox)

June 13, 2012 - Controversial Trade Pact Text Leaked - Investment Chapter of TPPA

June 8, 2012 - Reuters: China Changes Patent Law in Fight for Cheaper Drugs (links to Reuters)

June 8, 2012 - The New York Times: Obama Was Pushed by Drug Industry, E-mails Suggest (links the the NYTimes)

June 1, 2012 - Huffington Post: U.S. Trade Position Protecting High Drug Prices Blasted By U.N. Agencies (links to Huffington Post)

May 31, 2012 - UNAIDS/UNDP Press Release (links to Don't trade our lives away) | UNAIDS/UNDP Brief (Links to Asia-Pacific UNDP)

May 30, 2012 - Public Citizen Global Access to Medicines Program Director Peter Maybarduk:TPP Chiefs Raise Doubts about USTR's Corporate IP Wish List

May 25, 2012 - Public Citizen Global Access to Medicines Program Director Peter Maybarduk: "Heavy-handed" TPP Tactics from US Trade Rep

May 23, 2012 - Huffington Post: Key Senate Democrat Joins Bipartisan Trade Revolt Against Obama (links to Huffington Post)

May 22, 2012 - IP Watch: Nobel Laureate, Other Experts Hail WHO Effort on Medcines R&D Framework (links to

May 22, 2012 - Techdirt: Some Countries Want To Fix TPP…By Making It More Like ACTA (links to

May 22, 2012 - Public Citizen Health Research Group: Pharmaceutical Companies Must Be Held Fully Accountable for Defrauding the Government

May 18, 2012 - Pharmalot: Malaysians Seek License For Abbott AIDS Drug (links to Pharmalot)

May 17, 2012 - USTR Announces Next TPP Round in San Diego July 2-10 (links to

May 17, 2012 - Ars Technica: Exporting copyright: Inside the secretive Trans-Pacific Partnership (links to

May 16, 2012 - Melinda St. Louis of Public Citizen's Global Trade Watch talking jobs, medicines & TPP on RT News (links to & Maira Sutton of Electronic Frontier Foundation talking copyright, the internet & TPP on RT News (links to

May 16, 2012 - USTR Gone Rogue (links to

May 16, 2012 - Huffington Post: Darrell Issa Questions Obama On Trans-Pacific Partnership, Leaks Key Text Of Trade Deal (links to

May 16, 2012 - Focus Daily News: Texas rally and march for transparency in trade negotiations (links to

May 16, 2012 - Ars Technica: ACTA deathwatch: profs call process unconstitutional, Europe revolts (links to

May 16, 2012 - Melinda St. Louis of Public Citizen's Global Trade Watch talking jobs, medicines & TPP on RT News (links to & Maira Sutton of Electronic Frontier Foundation talking copyright, the Internet & TPP on RT News (links to

May 16, 2012 - USTR Gone Rogue (links to

May 16, 2012 - Huffington Post: Darrell Issa Questions Obama On Trans-Pacific Partnership, Leaks Key Text Of Trade Deal (links to

May 16, 2012 - News: Texas rally and march for transparency in trade negotiations (links to

May 16, 2012 - Ars Technica: ACTA deathwatch: profs call process unconstitutional, Europe revolts (links to

May 16, 2012 - Focus Daily News: Texas rally and march for transparency in trade negotiations (links to

May 15, 2012 - US Rep. Waxman says on TPP, the Obama administration "needs to go back to the drawing board ...not pose unnecessary barriers to poor patients seeking access to low cost generic medicines" (links to

May 15, 2012 - US Rep. Issa calls for public input on the Feb. 2011 leaked US TPP intellectual property (IP) proposal; calls for transparency in international IP agreements (links to

May 14, 2012 - TPP: Internet Freedom Activists Protest Secret Trade Agreement Being Negotiated This Week (links to

May 14, 2012 - ACTA-As-Counterproposal at TPP Negotiations; News from Dallas Round (links to

May 14, 2012 - Free Speech Radio News: Watchdogs push for more transparency in Pacific free trade deal (links to

May 13, 2012 - Reuters: Secrecy Needed in trade talks: Ron Kirk (links to

May 13, 2012 - The Raw Story: US Trade Rep. given 'Corporate Power Tool' award for secret treaty talks (links to

May 12, 2012 - Yes Lab: Party ends badly for U.S. trade reps, federal agents (links to

May 12, 2012 - Citizens Trade Campaign: Texans demand a public voice in secretive Trans-Pacific trade negotiations (links to

May 10, 2012 - Listen to Public Citizen's Global Access to Medicines Program Director Peter Maybarduk discussing the Trans-Pacific Partnership Agreement (TPP) on Free Speech Radio News (links to

May 10, 2012 - Kirk Responds to TPP Transparency Demands (links to

May 10, 2012 - Chile Threatens to Pull out of TPP because of US IP demands (links to

May 9, 2012 - Law Professors Call for Trans-Pacific Partnership (TPP) Transparency (links to

May 8, 2012 - Sen. Al Franken Urges Transparency on the Trans-Pacific Partnership (links to Minnesota Fair Trade Coalition)

May 8, 2012 - Citizen Trade Campaign: Coalition demands transparency in Trans-Pacific trade negotiations (link to

May 7, 2012 - The Dallas Morning News: Trade talks begin in Addison between U.S., eight other nations (link to

May 7, 2012 - Inter Press Service: Next Round of Pacific Trade Talks Pact to Be Lengthy, Secretive (

May 4, 2012 - Huffington Post: Why Is the TPP Such a Big Secret? (link to

May 3, 2012 - Huffington Post: Congress Revolts on Obama Plan That Would Ban "Buy American" (link to

April 21, 2012 - IP Watch: Kenyan High Court's Overturning of Anti-Counterfeit Law Hailed (links to

April 20, 2012 - I Love Chile: Chilean Officials Question Benefits of Trans-Pacific Partnership (links to

April 18, 2012 - Diario Financiero: Senador Ricardo Lagos Weber - Acuerdo Transpacífico contenidos y legitimidad

April 13, 2012 - Techdirt: Once Again, Public Interest Groups Kicked Out When Trying To Present Concerns About TPP (link to

April 12, 2012 - Briefing Memo: Chile and the Trans-Pacific Partnership Agreement - Access to Medicines Risks & Continued Bullying from USTR

April 12, 2012 - Huffington Post: "Next SOPA" Going Global? (links to

April 10, 2012 - Public Citizen: U.S. Abandons Final Pretense of Transparency or Inclusion of Consumer, Health, Environmental, Labor Perspective in Trans-Pacific Partnership (TPP) Talks (link to

April 5, 2012 - US Decreases Stakeholder Process for TPP (links to

April 4, 2012 - US Abbandons TPPA 'fig-leaf of transparency' (links to

March 20, 2012 - Wyden files legislative amendments to require transparency in TPPA and Congressional approval for ACTA (links to

March 20, 2012 - The Conversation: Australia should defend neighbors in Trans-Pacific Partnership negotiations (links to

March 19, 2012 - Expanding Access to Treatment for Hepatitis C in Resource-LImited Settings: Lessons from HIV/AIDS (Clinical Infectious Diseases Advance Access)

March 19, 2012 - Pharma in Focus: Alphapharm raises trade pact fear (link to

March 15, 2012 - Unanimously passed Maine House Resolution calling for transparency in the Trans-Pacific Partnership Agreement (TPPA) (links to

March 14, 2011 - GTPI supports judicial decision annulling patent HIV/AIDS medicine (link to

March 13, 2012 - Lori Wallach of Public Citizen's Global Trade Watch on the TPP: A Stealth Attack on Democratic Governance (links to

March 12, 2012 - Knowledge Ecology International (KEI) Notes From the Eleventh Round of TPPA negotiations in Melbourne, Australia (links to

March 12, 2012 - Comments from James Love of Knowledge Ecology International (KEI) on the granting of compulsory license on patents for the cancer drug sorafenib tosylate by India and news articles on the license (links to

March 12, 2012 - First ever compulsory license granted in India for the cancer drug sorafenib tosylate

March 9, 2012 - Decisão da Justiça anula patente de droga anti-Aids (link to Brazilian court annuls patent on HIV/AIDS medicine (Kaletra) (in Portuguese)

March 9, 2012 - Inter Press Service News Agency: Trans-Pacific Trade Pact Reveals U.S.'s Unbridled Corporate Agenda

March 8, 2012 - Civil Society requests TPP Chilean negotiations information from President Pinera

March 7, 2012 - Senator Ron Wyden presses USTR Kirk on ACTA and TPP secrecy (links to

March 6, 2012 - Deborah Gleeson of La Trobe University on Australian radio discussing the Trans-Pacific Free Trade Agreement (TPP) and investor-state dispute settlement, tobacco control & access to medicines (links to

March 6, 2012 - Judit Rius of Médecins Sans Frontières/Doctors Without Borders on Australian radio discussing the Trans-Pacific Free Trade Agreement (TPP) and access to medicines (links to

March 5, 2012 - Kelly Nichols of Médecins Sans Frontières/Doctors Without Borders op-ed in Canberra Times on the Trans-Pacific Free Trade Agreement (TPP) and access to medicines (links to

March 1, 2012 - Rob Lake of the Australian Federation of AIDS Organisations on Australian radio discussing TPP and access to medicines

February 29, 2012 - Over 100 Vietnamese health advocacy groups release declaration on the Trans-Pacific FTA and access to medicines

February 21, 2012 - IP-Watch, Special Report: "TPP negotiations to heat up in Melbourne over patents, copyright, medicines" (link to

February 10, 2012 - NHK World: Malaysia: Opposing the TPP (links to

February 10, 2012 - Amnesty International: ACTA a "Pandora's Box" of Potential Human Rights Violations; EU Governments Should Not Join

February 9, 2012 - Health Groups' Letter to U.S. Secretary of Commerce Against Corporate Sponsorship of Africa IP Forum (KEI, MSF, Health GAP, Oxfam, The George Washington University & Public Citizen)

February 5, 2012 - New York Times on ACTA threat to internet and access to medicines (links to

February 2, 2012- - Big Money's Next Trade Goal Is 'NAFTA With Asia' (links to

January 31, 2012 - Public Citizen Applauds EU Commission Call for Removal of Linkage Between Patents and Generic Medicines Authorization

January 31, 2012 - Webcast of Public Forum on IP and the Trans-Pacific FTA - Panels discuss copyright provisions & provisions affecting access to medicines - Fast -forward to 1:33:15 for PC Access to Medicines Program Director Peter Maybarduk (links to

January 30, 2012 - Obama's Free Trade Agreement: Backdoor Deal with Corporate America? (link to

January 26, 2012 - KEI asks Senator Leahy (D-VT) to demand greater transparency in the Trans-Pacific free trade agreement (links to

January 13, 2012 - KEI Comment for House Committee on Ways & Means Hearing on Trans-Pacific Free Trade Agreement and KEI Reponse to Federal Register notice seeking comments regarding Canada's interest in Trans-Pacific FTA negotiations (both link to

January 5, 2012 - Public Citizen Global Access to Medicines Program Director Peter Maybarduk's Presentation on Access to Medicines & IP Enforcement at American University Washington College of Law (June 2010)

January 5, 2012 - Public Citizen Global Access to Medicines Program Director Peter Maybarduk's Presentation on ACTA at American University Washington College of Law (June 2010)

December 22, 2011 - A brief history of Johnson & Johnson's refusal to negotiate with the Medicines Patent Pool

December 21, 2011 - Abbott Laboratories responds with letter to the Vietnam Network of People Living with HIV

December 20, 2011 - Working Group on International Property (GTPI) on Brazilian Patent Office's decision to prioritize examination of the patent application related to heat-stable ritonavir and lopinavir/ritonavir (links to

December 19, 2011 - Charts comparing pharmaceutical patent and data provisions in leaked U.S. proposals to the TPFTA, TRIPS Agreement and FTAs in negotiating countries (now with long and short form versions

December 16, 2011 - PC's Op-ed in the Advocate: U.S. AIDS Policy vs. U.S. Trade Policy

December 15, 2011 - Johnson & Johnson response to Public Citizen letter on the Medicines Patent Pool

December 13, 2011 - KPFA Radio Interview with Global Access to Medicines Program Director, Peter Maybarduk; Matt Kavanagh, HealthGAP; & Ellen Shaffer, CPATH (recorded December 2, 2011)

December 10, 2011 - Public Citizen Brief on the Medicines Patent Pool

December 9, 2011 - Dr. Burcu Kilic's presentation on innovation and intellectual property systems at the Malaysian round

December 7, 2011 - Today, Public Citizen sent a letter to Tibotec/Johnson & Johnson urging them to negotiate licensing with the Medicines Patent Pool

December 5, 2011 - Chart comparing pharmaceutical patent and data provisions in leaked U.S. proposals to the TPFTA, TRIPS Agreement and FTAs in negotiating countries

December 1, 2011 - AIDS Treatment Revolution: Expand Generic Competition (links to

December 1, 2011 - Public Citizen World AIDS Day Statement: Expanding Global AIDS Treatment Through Generic Competition

November 22, 2011- - Oxfam Paper on the Trans-Pacific FTA Leaked U.S. IP Chapter Proposal

November 21, 2011 - Clinton's Global AIDS Fight May Be Hurt by U.S. Trade Initiative (links to

November 18, 2011 - Celebrating the 10th Anniversary of the Doha Declaration

November 16, 2011 - Global Action To Open Generic Competition For Key AIDS Drug (links to

November 15, 2011 - Public Citizen Global Access to Medicines Program Responds to PhRMA's Claims on the Trans-Pacific Free Trade Agreement in The Hill (links to

November 11, 2011 - Sign on to Health GAP's letter to President Obama asking him to scale up ARV treatment

November 10, 2011 - MSF: Brazilians demand greater access to crucial HIV drug (links to

November 10, 2011 - The Guardian: Unprecedented global campaign launches against pharma company (links to

November 10, 2011 - Pharmalot: Activists Challenge Abbott Over Its AIDS Drug (links to

November 9, 2011 - Public Health Groups Launch Global Campaign Against Abbott Labs’ Monopoly on Critical AIDS Medicine

November 1, 2011 - Bangkok Post Editorial: Obama Administration Rolling Back Bush-era Stance on Access to Medicines; Opposition Abroad and Among NGOs is Near-Unanimous

October 25, 2011 - Spanish Translation of Public Citizen Global Access to Medicines Program's Summary of the Impact of the U.S. Proposal to the Trans-Pacific Partnership on Access to Medicines in Peru and Spanish Translation of Public Citizen's Comparative Analysis of the US Trans-Pacific FTA Proposal and Peruvian Law

October 24, 2011 - Stakeholder Forum Presentation Paper of Sharon Treat at the Lima Round of Trans-Pacific FTA Negotiations

October 24, 2011 - Stakeholder Forum Presentation of Edward Low (Positive Malaysian Treatment Access and Advocacy Group) at the Lima Round of Trans-Pacific FTA Negotiations

October 22, 2011 - Professor Sean Flynn's reaction to the leaked Trans-Pacific FTA Chapter on Transparency (links to and Professor Jane Kelsey’s Preliminary Analysis of the Draft Chapter on Domestic Coherence (links to

October 22, 2011 - Public Citizen Global Access to Medicines Program's Summary of the Impact of the U.S. Proposal to the Trans-Pacific Partnership on Access to Medicines in Peru

October 22, 2011 - Public Citizen's Comparative Analysis of the US Trans-Pacific FTA Proposal and Peruvian Law

October 22, 2011 - Leaked Trans-Pacific FTA Texts Reveal U.S. Undermining Access to Medicines (links to

October 19, 2011 - Congressional Letter to USTR on Preserving Access to Medicines in the Trans-Pacific FTA

October 14, 2011 - Vietnam and the Trans-Pacific FTA (Vietnamese Translation)

October 14, 2011 - Civil Society letter to Peruvian Minister of Trade: IP and Access to Medicines

October 13, 2011 - US Sen. Bernie Sanders speech on FTAs' Negative Impact on Access to Medicines

October 12, 2011 - Oxfam America Analysis of USTR TEAM White Paper

October 11, 2011 - Excerpts of "New Trade Deal Would Benefit Big Pharma at AIDS Programs' Expense (Vietnamese Translation)

October 7, 2011 - International Coalition of Treatment Activists: Letter to President Ollanta Humala Tasso regarding impact of TPP on the health of people with HIV in Peru

October 5, 2011 - New Trade Deal Would Benefit Big Pharma At AIDS Programs' Expense (link to

October 4, 2011 - Prosa letter to President Ollanta Humala Tasso: requesting the President to take a position against TPP and US patent protection periods

September 30, 2011 - Summary of Peruvian News Stories on IP, the Trans-Pacific FTA, and Dangers to Access to Medicines

September 9, 2011 - Comparative Analysis of the U.S. Intellectual Property Proposal and Malaysian Law

September 5, 2011 - Malaysian Declaration on the Trans-Pacific FTA and Access to Medicines

September 2, 2011 - Comparative Analysis of the U.S. Intellectual Property Proposal and Australian Law

September 2, 2011 - "Patent Talks Lift Fear of Drug Price Rise" (links to

September 1, 2011 - "New Trade Agreement Threatens Australia's Laws on Medicines and Tobacco" (links to

August 30, 2011 - "ACTA, TPPA Opponents Cite Broken Promises On Medicines, One-Sided Copyright Provisions" (links to

August 29, 2011 - Sign on Now to this Statement of Solidarity with Beaten Korean AIDS Activists

August 2, 2011 - Members of Congress Stand up for Access to Medicines in the Trans-Pacific FTA

July 27, 2011 - Public Citizen Quoted in New York Times Article, "A Trade Barrier to Defeating AIDS"

July 8, 2011 - Analysis of Leaked U.S. Paper on Eliminating Patent Pre-Grant Opposition

July, 2011 - Leaked U.S. TPPA Paper on Eliminating Pre-grant Opposition

June 16, 2011 - Comparative Analysis of the U.S. Intellectual Property Proposal and Vietnamese Law

June 16, 2011 - Vietnam and the Trans-Pacific Partnership Agreement

May 10, 2011 - Leaked Cables Show U.S. Tried, Failed to Organize Against Ecuador Compulsory Licensing

February 23, 2011 - Trans-Pacific FTA Agreement: Leaked Intellectual Property Proposals - New Zealand: Proposed IP Chapter Text

February 23, 2011 - Trans-Pacific FTA Agreement: Leaked Intellectual Property Proposals - Chile: Preliminary Considerations for TPP IP Chapter

February 17, 2011 - Trans-Pacific FTA: Leaked Intellectual Property Proposals: United States: Jane Kelsey, "New Leaks of TPPA Text Show U.S. is Playing Hardball"

February 17, 2011 - U.S. TPP Partial IPR Text Goes Beyond Old FTA Provisions On Copyrights

February 15, 2011 - Letter from Trans-Pacific FTA Member Countries Health Groups to Trade Ministers on Safeguarding Access to Medicines in the Trans-Pacific Partnership Agreement (En Espanol),

February 14, 2011 - Civil Society letter to Chilean Minister of Foreign Relations: Requesting public access to TPP text and collaboration with civil society

February 10, 2011 - Leaked US Proposed IP Text to the Trans-Pacific FTA (links to

December 4, 2010 - Why the Trans Pacific Partnership Should Not Include Pharmaceutical Pricing Provisions, Program on Information Justice and Intellectual Property (PIJIP) at American University Washington College of Law

December 4, 2010 - Memo on Trans-Pacific FTA Negotiations and Access to Medicines

December 4, 2010 - Press Release: Leaked New Zealand Paper Challenges U.S. FTA Models in Trans-Pacific Trade Negotiations; Access to Medicines at Stake

December 3, 2010 - Analysis of the Leaked New Zealand Paper on IP and TPP, Public Citizen and Third World Network

December 3, 2010 - Leaked New Zealand Paper on Intellectual Property and the Proposed Trans-Pacific FTA

November 19, 2010 - Comments on USPTO Proposal for Incentivizing Humanitarian Licensing of Patented Technologies, joint submission with Medicins Sans Frontieres, Oxfam America and Knowledge Ecology International

September 2010 - One Year of the Peru-U.S. FTA: Study results in Spanish, Peruvian Network for Globalization with Equity (RedGE)

September 2010 - ACTA and Public Health;(links to

September 30, 2010 - Public Citizen letter to Indian Department of Industrial Policy and Promotion (DIPP) on compulsory licensing

September 10, 2010 - ACTA's Scope and Access to Medicines

September 9, 2010 - Coalition Letter on the Proposed Trans Pacific FTA and Global Access to Medicines

May 25, 2010 - Comments to the European Commission on Customs Regulation 1383/2003

May 5, 2010 - Public Citizen letter to Dr. Margaret Chan, Director General of WHO on NGO access at the 2010 World Health Assembly

April 22, 2010 - Press Release: By Authorizing Generic Competition, Ecuador Cuts Cost of Key HIV/AIDS Drug

August, 2009 - Ecuadorian Institute for Intellectual Property: Administrative Guide for the issuance of compulsory licenses for pharmaceutical products in Ecuador

July 2, 2009 - Essential Action letter to Consultations and Liaison Division (BSL) of Foreign Affairs and International Trade Canada on ACTA

June 30, 2009 - Inter-American Dialogues: Will Venezuela Move to Modify Pharmaceutical Patents?

November 25, 2008 - Civil Society Letter to Dr. Gutierrez: Proposal to increase access to HIV treatment in Ecuador

March 21, 2008 - Essential Action Letter to USTR Director for IP: Comments on the Proposal of an Anti-Counterfeiting Trade Agreement

July 20, 2007 - Public Citizen: Envisioning a public interest response to counterfeiting and drug quality

Back to Access to Medicines Home Page